Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Minerva Neurosciences, Inc.
About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company is involved in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and has exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson’s disease. It has also co-developed seltorexant for the treatment of insomnia disorder and adjunctive treatment of major depressive disorder (MDD). Seltorexant is an innovative selective orexin 2 receptor antagonist. Its Roluperidone is a compound that has been shown to block serotonin, sigma, and α-adrenergic receptors that are involved in the regulation of mood, cognition, sleep and anxiety. Roluperidone has been designed to block a specific subtype of serotonin receptor called 5-HT2A.
Find out what a historical investment in Minerva Neurosciences, Inc. would be worth today using our NERV stock calculator.
Market Capitalisation
$245.06M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
84.01K
High today
$5.57
Low today
$5.20
Open price
$5.34
52-week high
$12.46
52-week low
$1.35
Ready to start your investing journey with Stake?
Open an accountHow do I buy NERV shares in Australia?
Buying NERV shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Minerva Neurosciences, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NERV
What is the ticker symbol of Minerva Neurosciences, Inc.?
The ticker symbol for Minerva Neurosciences, Inc. is NERV.
How much is one share of NERV?
One share of NERV is valued at $5.27 as of 23 May 2026.
What is the market capitalisation of Minerva Neurosciences, Inc. NERV?
As of 23 May 2026 Minerva Neurosciences, Inc. has a market cap of $245.06M.
What is the 52-week high for Minerva Neurosciences, Inc. stock?
The Minerva Neurosciences, Inc. 52-week high stock price is $12.46.
What is the 52-week low for Minerva Neurosciences, Inc. stock?
The Minerva Neurosciences, Inc. 52-week low stock price is $1.35.
Can I buy NERV shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NERV shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NERV on Stake
- Buy NERV from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NERV from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NERV related stocks